BBW vs JAZZ · P/E 12, rev $496.4M vs P/E 1988, rev $4.07B
Build-A-Bear Workshop Inc (BBW) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Build-A-Bear Workshop Inc (BBW) is a specialty retail company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported BBW revenue for 2025-02-01 was $496.4M. Net income was $51.8M. Revenue was up 2.1% from 2024-02-03 to 2025-02-01. BBW currently screens at market cap $683.5M and trailing P/E 12.2.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
BBW currently screens at market cap $683.5M and trailing P/E 12.2. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the BBW and JAZZ stock pages for the full models.
Not investment advice.